Literature DB >> 20228203

Plasmodium falciparum PF10_0164 (ETRAMP10.3) is an essential parasitophorous vacuole and exported protein in blood stages.

Drew C Mackellar1, Matthew T O'Neill, Ahmed S I Aly, John B Sacci, Alan F Cowman, Stefan H I Kappe.   

Abstract

Upregulated in infectious sporozoites gene 4 (UIS4) encodes a parasitophorous vacuole membrane protein expressed in the sporozoite and liver stages of rodent malaria parasites. Parasites that lack UIS4 arrest in early liver-stage development, and vaccination of mice with uis4(-) sporozoites confers sterile protection against challenge with infectious sporozoites. Currently, it remains unclear whether an ortholog of UIS4 is carried in the human malaria parasite Plasmodium falciparum, although the gene PF10_0164 has been identified as a candidate ortholog for UIS4 on the basis of synteny and structural similarity of the encoded protein. We show that PF10_0164 is expressed in sporozoites and blood stages of P. falciparum, where it localizes to the parasitophorous vacuole, and is also exported to the host erythrocyte. PF10_0164 is refractory to disruption in asexual blood stages. Functional complementation was tested in Plasmodium yoelii by replacing the endogenous copy of UIS4 with PF10_0164. PF10_0164 localized to the parasitophorous vacuole membrane of liver stages, but transgenic parasites did not complete liver-stage development in mice. We conclude that PF10_0164 is a parasitophorous vacuole protein that is essential in asexual blood stages and that does not complement P. yoelii UIS4, and it is thus likely not a functional ortholog of UIS4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228203      PMCID: PMC2863949          DOI: 10.1128/EC.00336-09

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  33 in total

1.  Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination.

Authors:  Alexander G Maier; Joanna A M Braks; Andrew P Waters; Alan F Cowman
Journal:  Mol Biochem Parasitol       Date:  2006-07-25       Impact factor: 1.759

Review 2.  The silent path to thousands of merozoites: the Plasmodium liver stage.

Authors:  Miguel Prudêncio; Ana Rodriguez; Maria M Mota
Journal:  Nat Rev Microbiol       Date:  2006-11       Impact factor: 60.633

3.  Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species.

Authors:  Olivier Silvie; Céline Greco; Jean-François Franetich; Anne Dubart-Kupperschmitt; Laurent Hannoun; Geert-Jan van Gemert; Robert W Sauerwein; Shoshana Levy; Claude Boucheix; Eric Rubinstein; Dominique Mazier
Journal:  Cell Microbiol       Date:  2006-07       Impact factor: 3.715

4.  Multiple sequence alignment with hierarchical clustering.

Authors:  F Corpet
Journal:  Nucleic Acids Res       Date:  1988-11-25       Impact factor: 16.971

5.  Inhibitory monoclonal antibody against a (myristylated) small-molecular-weight antigen from Plasmodium falciparum associated with the parasitophorous vacuole membrane.

Authors:  U A Kara; D J Stenzel; L T Ingram; G R Bushell; J A Lopez; C Kidson
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  Organization of ETRAMPs and EXP-1 at the parasite-host cell interface of malaria parasites.

Authors:  Tobias Spielmann; Donald L Gardiner; Hans-Peter Beck; Katharine R Trenholme; David J Kemp
Journal:  Mol Microbiol       Date:  2006-02       Impact factor: 3.501

7.  Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers.

Authors:  John B Sacci; Uzma Alam; Donna Douglas; Jamie Lewis; D Lorne J Tyrrell; Abdu F Azad; Norman M Kneteman
Journal:  Int J Parasitol       Date:  2006-03       Impact factor: 3.981

8.  Genome-wide identification of genes upregulated at the onset of gametocytogenesis in Plasmodium falciparum.

Authors:  Francesco Silvestrini; Zbynek Bozdech; Alessandra Lanfrancotti; Eugenia Di Giulio; Emanuele Bultrini; Leonardo Picci; Joseph L Derisi; Elisabetta Pizzi; Pietro Alano
Journal:  Mol Biochem Parasitol       Date:  2005-09       Impact factor: 1.759

9.  Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.

Authors:  Ann-Kristin Mueller; Nelly Camargo; Karine Kaiser; Cathy Andorfer; Ute Frevert; Kai Matuschewski; Stefan H I Kappe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

10.  A Plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes.

Authors:  Taco W A Kooij; Jane M Carlton; Shelby L Bidwell; Neil Hall; Jai Ramesar; Chris J Janse; Andrew P Waters
Journal:  PLoS Pathog       Date:  2005-12-23       Impact factor: 6.823

View more
  22 in total

1.  Protein targeting to the parasitophorous vacuole membrane of Plasmodium falciparum.

Authors:  Saliha Eksi; Kim C Williamson
Journal:  Eukaryot Cell       Date:  2011-04-15

2.  A systematic analysis of the early transcribed membrane protein family throughout the life cycle of Plasmodium yoelii.

Authors:  Drew C MacKellar; Ashley M Vaughan; Ahmed S I Aly; Sasha DeLeon; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2011-08-31       Impact factor: 3.715

Review 3.  Translational control in Plasmodium and toxoplasma parasites.

Authors:  Min Zhang; Bradley R Joyce; William J Sullivan; Victor Nussenzweig
Journal:  Eukaryot Cell       Date:  2012-12-14

4.  Complete Plasmodium falciparum liver-stage development in liver-chimeric mice.

Authors:  Ashley M Vaughan; Sebastian A Mikolajczak; Elizabeth M Wilson; Markus Grompe; Alexis Kaushansky; Nelly Camargo; John Bial; Alexander Ploss; Stefan H I Kappe
Journal:  J Clin Invest       Date:  2012-09-10       Impact factor: 14.808

5.  Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.

Authors:  Sebastian A Mikolajczak; Ashley M Vaughan; Niwat Kangwanrangsan; Wanlapa Roobsoong; Matthew Fishbaugher; Narathatai Yimamnuaychok; Nastaran Rezakhani; Viswanathan Lakshmanan; Naresh Singh; Alexis Kaushansky; Nelly Camargo; Michael Baldwin; Scott E Lindner; John H Adams; Jetsumon Sattabongkot; Jetsumon Prachumsri; Stefan H I Kappe
Journal:  Cell Host Microbe       Date:  2015-03-19       Impact factor: 21.023

6.  An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes.

Authors:  Amed Ouattara; Ankit Dwivedi; Matthew Adams; Amadou Niangaly; Matthew B Laurens; Myaing M Nyunt; Christopher V Plowe; Abdoulaye Djimde; Shannon Takala-Harrison; Joana C Silva
Journal:  Microorganisms       Date:  2022-05-25

Review 7.  Development of humanized mouse models to study human malaria parasite infection.

Authors:  Ashley M Vaughan; Stefan H I Kappe; Alexander Ploss; Sebastian A Mikolajczak
Journal:  Future Microbiol       Date:  2012-05       Impact factor: 3.165

8.  The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).

Authors:  Jaime R Adame-Gallegos; Jianguo Shi; Richard S McIntosh; Richard J Pleass
Journal:  Exp Parasitol       Date:  2012-02-10       Impact factor: 2.011

9.  The ETRAMP family member SEP2 is expressed throughout Plasmodium berghei life cycle and is released during sporozoite gliding motility.

Authors:  Chiara Currà; Marco Di Luca; Leonardo Picci; Carina de Sousa Silva Gomes dos Santos; Inga Siden-Kiamos; Tomasino Pace; Marta Ponzi
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro.

Authors:  Anne-Marie Zeeman; Sandra M van Amsterdam; Case W McNamara; Annemarie Voorberg-van der Wel; Els J Klooster; Alexander van den Berg; Edmond J Remarque; David M Plouffe; Geert-Jan van Gemert; Adrian Luty; Robert Sauerwein; Kerstin Gagaring; Rachel Borboa; Zhong Chen; Kelli Kuhen; Richard J Glynne; Arnab K Chatterjee; Advait Nagle; Jason Roland; Elizabeth A Winzeler; Didier Leroy; Brice Campo; Thierry T Diagana; Bryan K S Yeung; Alan W Thomas; Clemens H M Kocken
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.